# SCARAB GENOMICS, LLC: Development of a continuous microbial fermentation system using reduced genome E. coli that undergo programmed autolysis and generate nuclease post-production for the manufacture of biopharmaceuticals

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | SCARAB GENOMICS, LLC |
| Location | MADISON, WI |
| Project | Development of a continuous microbial fermentation system using reduced genome E. coli that undergo programmed autolysis and generate nuclease post-production for the manufacture of biopharmaceuticals |
| Project number | 5R44GM161364-02 |
| Mechanism | R44 |
| Institute | National Institute of General Medical Sciences |
| Award | $917,119 |
| Awarded | 2026-09-02 |
| Project period | 2025-09-15 to 2027-08-31 |
| UEI | S4XQJDL7DN15 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11415147). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.